Navigation Links
Sepsis Therapy in Preemies Fails to Boost Survival
Date:1/16/2009

Study suggests future treatments should focus on wider view of antibacterial defenses

FRIDAY, Jan. 16 (HealthDay News) -- Boosting the immune systems of premature babies with blood cell growth factor fails to prevent sepsis or improve survival rates, a new study shows.

Premature babies, especially those with lower than normal birth weight, tend to be prone to infections from low white blood cell counts. Blood growth factors, such as granulocyte-macrophage colony stimulating factor (GM-CSF), increase white blood cell counts and are often used in cancer patients to counter immune suppression caused by chemotherapy.

The London-based study, published in the current issue of The Lancet, found giving GM-CSF to premature babies with low birth weight did increase their white counts but, when compared with preterms who did not receive the treatment, they did not have lower rates of infection or better survival rates.

"We believe that, before embarking on future single-agent clinical trials, we should consider if this is too simplistic an approach to sepsis prevention in the preterm infant, whose immune system appears compromised in many different ways. ... Successful future stratagems will need a wider view of their antibacterial defenses," wrote the authors, lead by Robert Carr of Guy's and St Thomas Hospital NHS Trust in London.

More information

The U.S. National Library of Medicine has more about sepsis.



-- Kevin McKeever



SOURCE: The Lancet, news release, Jan. 15, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Medical Simulation Corporation Introduces Sepsis Quality Initiative Program
2. Educational Drive Cut Death Rate From Sepsis
3. Ashwell receptor reduces mortality during sepsis
4. Customized treatments for sepsis lower treatment time and reduce length of ICU stays
5. Research May Yield New Weapons Against Sepsis
6. Blacks More Likely to Die of Severe Sepsis
7. Scientists Probe Sepsis Deadly Secrets
8. Estonian Cancer Patients Have Access to More Conformal Radiotherapy Treatments for First Time with Unveiling of Advanced Varian Treatment Machine
9. Hispanics Respond Poorly to Standard Hepatitis C Therapy
10. UNC study supports role of circadian clock in response to chemotherapy
11. North Carolina Company Announces First Chronic Pain Control Unit Combining Two Most Used Forms of Electrotherapy For Chronic Pain - Tens & Interferential
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sepsis Therapy in Preemies Fails to Boost Survival 
(Date:4/28/2017)... ... April 28, 2017 , ... Accreditation Commission for Health Care ... of America (HCAOA). This agreement allows HCAOA members to receive special pricing on ... on Accreditation University (AU) educational resources that help prepare HCAOA members for ACHC ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Bill Howe ... industry in the coastal communities. After Tina Howe joined the team, the Bill Howe ... employees, honest services at affordable rates, and giving back to the San Diego community ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- Vivify Health, the pioneer and market leader of remote ... significant patent for the advancement of healthcare delivery from ... health.  This landmark patent provides the company with broad ... position as the leader in remote care.  ... to apply consumer mobile devices, wireless biometrics, EMR integration ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Injectables Market and Increasing Usage of Complex Biologics during the Forecast ... ... USD 20 Billion in 2015 to around USD 26 Billion by ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology: